Profile | GDS4284 / 202506_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1700.4 | 82 |
GSM687648 | Patient 402 control | 1644.18 | 81 |
GSM687653 | Patient 403 control | 1159.72 | 76 |
GSM687658 | Patient 404 control | 1318.33 | 78 |
GSM687663 | Patient 411 control | 1030.11 | 74 |
GSM687668 | Patient 422 control | 1415.78 | 79 |
GSM687673 | Patient 424 control | 1144.52 | 76 |
GSM687678 | Patient 425 control | 1535.51 | 80 |
GSM687683 | Patient 427 control | 1502.42 | 80 |
GSM687688 | Patient 428 control | 1204.1 | 77 |
GSM687695 | Patient 441 control | 2999.64 | 90 |
GSM687699 | Patient 443 control | 1284.01 | 78 |
GSM687704 | Patient 444 control | 1029.16 | 74 |
GSM687707 | Patient 448 control | 1324.95 | 78 |
GSM687712 | Patient 449 control | 1643.99 | 81 |
GSM687719 | Patient 450 control | 1881.24 | 83 |
GSM687724 | Patient 451 control | 1439.22 | 80 |
GSM687728 | Patient 452 control | 3127.02 | 89 |
GSM687646 | Patient 401 treated 24h | 1365.99 | 78 |
GSM687649 | Patient 402 treated 24h | 1798.03 | 82 |
GSM687665 | Patient 411 treated 24h | 1392.48 | 79 |
GSM687651 | Patient 402 treated 4 weeks | 1257.26 | 77 |
GSM687667 | Patient 411 treated 4 weeks | 1335.15 | 78 |
GSM687670 | Patient 422 treated 24h | 1828.72 | 82 |
GSM687671 | Patient 422 treated 4 weeks | 1610.72 | 81 |
GSM687654 | Patient 403 treated 24h | 1147.27 | 76 |
GSM687675 | Patient 424 treated 24h | 1493.83 | 80 |
GSM687685 | Patient 427 treated 24h | 1286.19 | 78 |
GSM687656 | Patient 403 treated 4 weeks | 1138.26 | 76 |
GSM687677 | Patient 424 treated 4 weeks | 1074.43 | 75 |
GSM687687 | Patient 427 treated 4 weeks | 1385.52 | 78 |
GSM687692 | Patient 428 treated 4h | 1122.67 | 76 |
GSM687716 | Patient 449 treated 4h | 1409.05 | 79 |
GSM687722 | Patient 450 treated 4h | 1889.06 | 83 |
GSM687680 | Patient 425 treated 24h | 1755.98 | 82 |
GSM687690 | Patient 428 treated 24h | 1613.97 | 81 |
GSM687700 | Patient 443 treated 24h | 1958.67 | 84 |
GSM687705 | Patient 444 treated 24h | 1044.95 | 75 |
GSM687714 | Patient 449 treated 24h | 1844.48 | 83 |
GSM687721 | Patient 450 treated 24h | 2003.68 | 84 |
GSM687682 | Patient 425 treated 4 weeks | 1256.05 | 77 |
GSM687694 | Patient 428 treated 4 weeks | 1303.57 | 77 |
GSM687702 | Patient 443 treated 4 weeks | 1506.69 | 80 |
GSM687718 | Patient 449 treated 4 weeks | 1188.48 | 77 |
GSM687723 | Patient 450 treated 4 weeks | 1674.35 | 82 |
GSM687661 | Patient 404 treated 4h | 1509.93 | 80 |
GSM687710 | Patient 448 treated 4h | 1361.61 | 79 |
GSM687726 | Patient 451 treated 4h | 1634 | 81 |
GSM687730 | Patient 452 treated 4h | 929.671 | 72 |
GSM687660 | Patient 404 treated 24h | 4614.86 | 93 |
GSM687697 | Patient 441 treated 24h | 3770.77 | 91 |
GSM687709 | Patient 448 treated 24h | 1381.99 | 79 |
GSM687725 | Patient 451 treated 24h | 1770.34 | 83 |
GSM687729 | Patient 452 treated 24h | 5176.64 | 94 |
GSM687727 | Patient 451 treated 4 weeks | 1213.99 | 77 |
GSM687731 | Patient 452 treated 4 weeks | 2212.54 | 85 |